ArticleClinical and translational science2024
Predicting progression-free survival from measurable residual disease in chronic lymphocytic leukemia.
Florencia A Tettamanti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it